UPDATE: InformedDNA, Edimer Collaborate on Genetic Counseling Program for XLHED | GenomeWeb

The story has been corrected to state that InformedDNA is a genetics services firm, not a genetics testing company.

NEW YORK (GenomeWeb) – Genetic services firm InformedDNA today announced it is developing a genetic counseling program as part of a collaboration with Edimer Pharmaceuticals in support of the drug firm's clinical program directed at X-linked hypohidrotic ectodermal dysplasia (XLHED).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.